Lopes Milena Rosa, Direito Rosa, Guiguer Elen Landgraf, Catharin Vitor Cavallari Strozze, Zutin Tereza Lais Menegucci, Rubira Claudio José, Catharin Virgínia Maria Cavallari Strozze, Sloan Kátia Portero, Sloan Lance Alan, Junior José Luiz Yanaguizawa, Laurindo Lucas Fornari, Barbalho Sandra Maria, de Alvares Goulart Ricardo
Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília, SP, 17525-902, Brazil.
Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, 1649-003, Lisbon, Portugal.
Probiotics Antimicrob Proteins. 2025 Sep 6. doi: 10.1007/s12602-025-10680-6.
The symbiosis between intestinal bacteria and the human body's physiological processes can modulate health. The intestinal microbiota is linked to the development of neurotrophic factors; therefore, it is increasingly related to the modulation of nervous system pathologies. Moreover, microbiota can interfere with inflammation and oxidative stress, which are closely linked to cardiovascular risk factors and several other inflammatory conditions, such as kidney and neurodegenerative diseases. Probiotics are live microorganisms that help regulate and maintain healthy microbiota; thus, they can help prevent these diseases. Due to these reasons, this review aimed to evaluate the effects of probiotics on the gut, kidneys, brain, and heart homeostasis. Clinical trials showed several positive results with the treatment. In the brain, probiotics reduce depressive symptoms (decreases in HAMA, GAD-7, and BDI-II scales), improving patients' sleep quality and fatigue, enhancing cognitive subscales while slowing brain atrophy, and reducing IL-6 levels in the central areas, also modulating REM delta power to reduce high-frequency brain waves. Probiotics can also reduce cardiovascular risk factors, such as inflammation. Probiotics can also benefit the heart by decreasing TMAO, LDL-c, TG, CRP, MDA, TNF-α, IL-6, and urea levels, improving dyslipidemia and toxin profiles. Probiotics also increase HDL-c, ApoE, and insulin sensitivity, decreasing BMI, body fat, and the risk of developing chronic hyperglycemia while increasing lean mass. Besides, probiotic supplementation helped reduce toxic uremic toxins (serum urea) and sodium levels, bringing benefits to the kidneys, and improve energy/amino acid metabolism. Probiotics can also modulate and enhance kidney function due to decreased pro-inflammatory TGFβ-1 and TNF-α levels and RUNX2. Furthermore, enhanced gastrointestinal motility and diversity have been reported using specific bacteria. Although probiotics can bring several health benefits, there are still challenges regarding these supplements, such as dose, frequency, and pharmaceutical formula. Therefore, new studies are welcome to deepen the understanding of these microorganisms.
肠道细菌与人体生理过程之间的共生关系可调节健康。肠道微生物群与神经营养因子的发育有关;因此,它与神经系统疾病的调节越来越相关。此外,微生物群可干扰炎症和氧化应激,而炎症和氧化应激与心血管危险因素以及其他几种炎症性疾病(如肾脏和神经退行性疾病)密切相关。益生菌是有助于调节和维持健康微生物群的活微生物;因此,它们有助于预防这些疾病。由于这些原因,本综述旨在评估益生菌对肠道、肾脏、大脑和心脏稳态的影响。临床试验显示该治疗有几个积极结果。在大脑中,益生菌可减轻抑郁症状(汉密尔顿焦虑量表、广泛性焦虑障碍量表和贝克抑郁量表得分降低),改善患者的睡眠质量和疲劳,增强认知子量表,同时减缓脑萎缩,并降低中枢区域的白细胞介素-6水平,还可调节快速眼动睡眠期δ波功率以降低高频脑电波。益生菌还可降低心血管危险因素,如炎症。益生菌还可通过降低氧化三甲胺、低密度脂蛋白胆固醇、甘油三酯、C反应蛋白、丙二醛、肿瘤坏死因子-α、白细胞介素-6和尿素水平,改善血脂异常和毒素谱,从而对心脏有益。益生菌还可增加高密度脂蛋白胆固醇、载脂蛋白E和胰岛素敏感性,降低体重指数、体脂以及发生慢性高血糖的风险,同时增加瘦体重。此外,补充益生菌有助于降低尿毒症毒素(血清尿素)和钠水平,对肾脏有益,并改善能量/氨基酸代谢。由于促炎转化生长因子β-1、肿瘤坏死因子-α水平和RUNX2降低,益生菌还可调节和增强肾功能。此外,使用特定细菌已报告可增强胃肠动力和多样性。尽管益生菌可带来多种健康益处,但这些补充剂仍存在一些挑战,如剂量、频率和药物配方。因此,欢迎开展新的研究以加深对这些微生物的了解。